Baillie Gifford is closing its underperforming Health Innovation fund due to dwindling assets.
Officially launched in 2020 to take advantage of cutting-edge healthcare companies, the fund's assets under management have now fallen to £26m. Co-managed by Julia Angeles, Marina Record and Rose Nguyen and having been run internally for two years, the fund sits in the bottom quartile over several timescales, returning 4.4% over one year against the IA Healthcare average of 12.6%, according to FE fundinfo. Baillie Gifford to shutter four bond funds and scrap international fixed income business Following a strategic review, Baillie Gifford has concluded the fund is no longer comme...
To continue reading this article...
Join Investment Week for free
Signup and gain exclusive members-only insights - all free of charge!
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
